跳至主要内容
临床试验/IRCT20190210042676N22
IRCT20190210042676N22招募中2 期

Safety and efficacy of topical finasteride nanoemulgel 0.25% in the treatment of mild to moderate androgenetic alopecia on male and female pattern

Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 50 years(—)
性别
All

入选标准

  • Male or female aged 20-50 years
  • Hair Loss Status II, III, IV Based on Norwood Scale for men
  • Hair Loss Status I,II Based on Ludwick Scale for women
  • General health
  • Voluntary participation and signing written informed consent

排除标准

  • Chronic active scalp disease other than hair loss
  • Using any prescribed drug or over-the-counter(OTC) for hair loss within the past 3 months
  • Women with abnormal hormonal tests
  • Women with Polycystic ovary(PCO)
  • pregnancy or lactating women

研究者

相似试验